184 related articles for article (PubMed ID: 38689334)
1. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
[TBL] [Abstract][Full Text] [Related]
2. Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis.
Eckhardt BL; Cao Y; Redfern AD; Chi LH; Burrows AD; Roslan S; Sloan EK; Parker BS; Loi S; Ueno NT; Lau PKH; Latham B; Anderson RL
Cancer Res; 2020 Mar; 80(6):1304-1315. PubMed ID: 31941699
[TBL] [Abstract][Full Text] [Related]
3. Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251.
Liu B; Tian D; Yi W; Wu L; Cai Q; Dong H; Shen H; Ji B; Wang L; Zhang S; Ruan D; Chen Q
Cell Biochem Biophys; 2010 Nov; 58(2):91-6. PubMed ID: 20730570
[TBL] [Abstract][Full Text] [Related]
4. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
5. Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4.
Zuo H; Yang D; Wan Y
Cancer Res; 2021 Oct; 81(20):5242-5254. PubMed ID: 34433585
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.
Guo D; Huang J; Gong J
Mol Cell Biochem; 2012 Apr; 363(1-2):179-90. PubMed ID: 22167620
[TBL] [Abstract][Full Text] [Related]
7. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis.
Voorneveld PW; Stache V; Jacobs RJ; Smolders E; Sitters AI; Liesker A; Korkmaz KS; Lam SM; De Miranda NF; Morreau H; Kodach LL; Hardwick JC
Br J Cancer; 2013 Oct; 109(7):1805-12. PubMed ID: 23969729
[TBL] [Abstract][Full Text] [Related]
9. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER
Shee K; Jiang A; Varn FS; Liu S; Traphagen NA; Owens P; Ma CX; Hoog J; Cheng C; Golub TR; Straussman R; Miller TW
FASEB J; 2019 Feb; 33(2):1644-1657. PubMed ID: 30161001
[TBL] [Abstract][Full Text] [Related]
10. miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling.
Xie H; Liu M; Jin Y; Lin H; Zhang Y; Zheng S
J Orthop Surg Res; 2020 Jun; 15(1):237. PubMed ID: 32600409
[TBL] [Abstract][Full Text] [Related]
11. Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Chiou J; Su CY; Jan YH; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2017 Aug; 7(1):9830. PubMed ID: 28852126
[TBL] [Abstract][Full Text] [Related]
12. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
14. Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines.
Barros R; Pereira B; Duluc I; Azevedo M; Mendes N; Camilo V; Jacobs RJ; Paulo P; Santos-Silva F; van Seuningen I; van den Brink GR; David L; Freund JN; Almeida R
J Pathol; 2008 Aug; 215(4):411-20. PubMed ID: 18498120
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑431 inhibits the expression of surfactant proteins through the BMP4/activin/TGF‑β signaling pathway by targeting SMAD4.
Shen YQ; Bao ZD; Pan JJ; Mao XN; Cheng R; Zhou XG; Zhou XY; Yang Y
Int J Mol Med; 2020 May; 45(5):1571-1582. PubMed ID: 32323744
[TBL] [Abstract][Full Text] [Related]
16. Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.
Ketolainen JM; Alarmo EL; Tuominen VJ; Kallioniemi A
Breast Cancer Res Treat; 2010 Nov; 124(2):377-86. PubMed ID: 20182795
[TBL] [Abstract][Full Text] [Related]
17. The impact of bone morphogenetic protein 4 (BMP4) on breast cancer metastasis in a mouse xenograft model.
Ampuja M; Alarmo EL; Owens P; Havunen R; Gorska AE; Moses HL; Kallioniemi A
Cancer Lett; 2016 Jun; 375(2):238-244. PubMed ID: 26970275
[TBL] [Abstract][Full Text] [Related]
18. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
19. Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.
Cyr-Depauw C; Northey JJ; Tabariès S; Annis MG; Dong Z; Cory S; Hallett M; Rennhack JP; Andrechek ER; Siegel PM
Mol Cell Biol; 2016 May; 36(10):1509-25. PubMed ID: 26976638
[TBL] [Abstract][Full Text] [Related]
20. The role of Smad4 in vestibular development in mice.
Yang SM; Deng AC; Huang DL; Sun JH; Yang G; Yu YP; Hou ZH; Guo WW; Zhai SQ; He DZ; Han DY; Young WY; Yang X
Int J Dev Neurosci; 2011 Feb; 29(1):15-23. PubMed ID: 20969946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
